Advanced Search
Contact | Corporate | Help

Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer

Sponsors:
  • Sarah Cannon Research Institute
  • Prometheus Therapeutics and Diagnostics
  • Genentech
Phases:
IndicationsAcronym:
  • Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Procedure: PRO Onc Assay
  • Drug: Trastuzumab
  • Drug: Pertuzumab
Enrollment:
450

Additional information about NCT01048099.


SourceSolution © 2008-2012